Larson Financial Group LLC trimmed its position in shares of TTM Technologies, Inc. (NASDAQ:TTMI – Free Report) by 23.9% during the 3rd quarter, according to its most recent 13F filing with the SEC. The fund owned 12,199 shares of the technology company’s stock after selling 3,828 shares during the quarter. Larson Financial Group LLC’s holdings in TTM Technologies were worth $223,000 at the end of the most recent reporting period.
Several other institutional investors also recently bought and sold shares of TTMI. Vanguard Group Inc. grew its position in TTM Technologies by 0.5% during the 1st quarter. Vanguard Group Inc. now owns 13,610,120 shares of the technology company’s stock valued at $212,998,000 after purchasing an additional 63,073 shares during the last quarter. CANADA LIFE ASSURANCE Co grew its position in TTM Technologies by 6.9% during the 1st quarter. CANADA LIFE ASSURANCE Co now owns 90,880 shares of the technology company’s stock valued at $1,421,000 after purchasing an additional 5,870 shares during the last quarter. Price T Rowe Associates Inc. MD lifted its stake in TTM Technologies by 6.0% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 63,144 shares of the technology company’s stock valued at $989,000 after acquiring an additional 3,592 shares during the period. Comerica Bank lifted its stake in TTM Technologies by 9.4% during the 1st quarter. Comerica Bank now owns 116,629 shares of the technology company’s stock valued at $1,825,000 after acquiring an additional 9,999 shares during the period. Finally, Cascade Investment Advisors Inc. bought a new position in TTM Technologies during the 2nd quarter valued at about $457,000. 95.79% of the stock is owned by hedge funds and other institutional investors.
TTM Technologies Trading Down 0.4 %
TTM Technologies stock opened at $24.14 on Thursday. The firm has a 50 day moving average of $20.77 and a 200 day moving average of $19.74. The firm has a market capitalization of $2.46 billion, a price-to-earnings ratio of 36.58 and a beta of 1.22. TTM Technologies, Inc. has a 12-month low of $13.43 and a 12-month high of $25.49. The company has a current ratio of 2.00, a quick ratio of 1.70 and a debt-to-equity ratio of 0.59.
Insider Buying and Selling
Analysts Set New Price Targets
Several equities analysts have issued reports on the stock. B. Riley upped their target price on shares of TTM Technologies from $25.50 to $27.25 and gave the company a “buy” rating in a research note on Thursday, August 1st. Truist Financial restated a “buy” rating and set a $24.00 target price (up previously from $22.00) on shares of TTM Technologies in a research note on Thursday, August 1st. Needham & Company LLC upped their target price on shares of TTM Technologies from $24.00 to $26.00 and gave the company a “buy” rating in a research note on Thursday, October 31st. Finally, Stifel Nicolaus upped their target price on shares of TTM Technologies from $19.00 to $24.00 and gave the company a “buy” rating in a research note on Thursday, August 1st.
View Our Latest Research Report on TTM Technologies
About TTM Technologies
TTM Technologies, Inc, together with its subsidiaries, manufactures and sells mission systems, radio frequency (RF) components and RF microwave/microelectronic assemblies, and printed circuit boards (PCB) worldwide. The company operates in two segments, PCB and RF&S Components. It offers range of engineered systems, RF and microwave assemblies, HDI PCBs, flexible PCBs, rigid-flex PCBs, custom assemblies and system integration, IC substrates, passive RF components, advanced ceramic RF components, hi-reliability multi-chip modules, beamforming and switching networks, PCB products, RF components, and backplane/custom assembly solutions, including conventional PCBs.
Featured Articles
- Five stocks we like better than TTM Technologies
- What Are Trending Stocks? Trending Stocks Explained
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- Top Biotech Stocks: Exploring Innovation Opportunities
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- What Investors Need to Know to Beat the Market
- 2 Generic Drug Stocks Ready to Surge in 2025
Want to see what other hedge funds are holding TTMI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for TTM Technologies, Inc. (NASDAQ:TTMI – Free Report).
Receive News & Ratings for TTM Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TTM Technologies and related companies with MarketBeat.com's FREE daily email newsletter.